Dow Up0.08% Nasdaq Down0.30%

Aeolus Pharmaceuticals Inc. (AOLS)

-Other OTC
0.35 Down 0.04(10.26%) 3:56PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Sep 30, 2012Sep 30, 2011
Total Revenue 3,928   7,293   4,821  
Cost of Revenue -   -   -  
Gross Profit 3,928   7,293   4,821  
Operating Expenses
Research Development3,360  6,468  5,055  
Selling General and Administrative3,266  3,196  3,668  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (2,698) (2,371) (3,902)
Income from Continuing Operations
Total Other Income/Expenses Net(510)4,069  4,222  
Earnings Before Interest And Taxes(3,208)1,698  320  
Interest Expense -   -  21  
Income Before Tax(3,208)1,698  299  
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(3,208)1,698  299  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (3,208) 1,698   299  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (3,208) 1,698   299  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.